Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new look at pleoptics.

M Jablonski, E Tomlinson

    Ophthalmology
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Active pleoptic therapy offers a valuable treatment for amblyopia when conventional occlusion fails. This method successfully improved visual acuity and fusion in young patients, demonstrating long-term benefits.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

    Physical review letters·2026
    Same author

    Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

    Physical review letters·2025
    Same author

    Clinical outcomes following implementation of diagnostic testing for pre-eclampsia within a UK tertiary hospital setting using angiogenic biomarkers.

    Pregnancy hypertension·2025
    Same author

    First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.

    Physical review letters·2025
    Same author

    Probing Strangeness Hadronization with Event-by-Event Production of Multistrange Hadrons.

    Physical review letters·2025
    Same author

    Measurements of Chemical Potentials in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

    Physical review letters·2024
    Same journal

    Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

    Ophthalmology·2026
    Same journal

    Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

    Ophthalmology·2026
    Same journal

    Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma.

    Ophthalmology·2026
    Same journal

    Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

    Ophthalmology·2026
    Same journal

    Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

    Ophthalmology·2026
    Same journal

    Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

    Ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Vision Science

    Background:

    • Amblyopia treatment often involves conventional occlusion therapy.
    • Some patients do not respond adequately to passive conventional occlusion.

    Purpose of the Study:

    • To evaluate the efficacy of active pleoptic therapy followed by orthoptic therapy in amblyopic patients unresponsive to conventional occlusion.

    Main Methods:

    • Sixty-four amblyopic patients (ages 4-17) received active pleoptic therapy.
    • Orthoptic therapy was administered when fusion potential was evident.
    • Patient outcomes were assessed for visual acuity and fusion capabilities.

    Main Results:

    • All 64 patients achieved visual acuity of 20/30 or better post-therapy.
    • 25 patients demonstrated fusion and stereopsis immediately after therapy.

    Related Experiment Videos

  • Of 27 patients followed long-term (1-10 years), 88% maintained 20/30 or better acuity and fusion.

    • Conclusions:

    • Active pleoptic therapy is effective for amblyopic patients with steady or unsteady central fixation who have not responded to conventional occlusion.
    • The therapy demonstrates lasting benefits in visual acuity and fusion maintenance.